SlideShare a Scribd company logo
PHARMACEUTICAL MICROBIOLOGY (BP303T)
Unit-III
Part-6
Sterility testing products (solids, liquids, ophthalmic and other
sterile products) according to IP, BP, USP.
Name: Ms. Pooja Deepak Bhandare
Assistant Professor
G H RAISONI UNIVERSITY
SCHOOL OF PHARMACY
Introduction
• Sterilization is the process of complete removal of microorganisms
from any surface or product.
• Sterility hence can be defined as “Complete freedom from
microorganisms”.
• The tests for sterility are conducted to make sure there is complete
absence of viable forms of microorganisms on a pharmaceutical
product.
• The products which are to be strictly supervised for absence of the
microorganisms are those who come directly in contact with the
systemic circulation e.g. ophthalmic preparations, parenteral
injections, implants, bandages, surgical dressings, needles, surgical
instruments etc.
• The test for sterility has to be conducted in aseptic environment so as to
avoid the contamination of the product.
• A pyrogen can be defined as “Fever Producing Substance”, which
induces “Fever (Hyperpyrexia)”.
• Bacterial endotoxins are the most common type of “Exogenous
Pyrogen”.
• Bacteria, viruses, malaria parasites and fungi on entering in the body
releases certain chemicals that act as Pyrogen.
• During the sterilization process these microorganisms die but presence of
pyrogens in the products may cause a febrile reaction.
• Test for sterility ensures absence of microorganisms while the
Pyrogen test ensures absence of pyrogens in the pharmaceutical
products.
• The lipopolysaccharide (LPS) from gram negative bacterias is a very
common example of pyrogen.
• The common pyrogen tests are,
• LAL Test (Limulus Amoebecyte Lysate Test).
• Sham Test (Rabbit Test).
Test for Sterility.
• Principle:
• A viable microorganism when provided with favorable conditions and
nutrients shows growth indicating its presence in the product.
• The probability of detecting the microbes in a product increases with
the number of the testings done.
• The external surfaces of the ampoules and vials or the containers
should be cleaned with the suitable antimicrobial substance and test be
carried out in an aseptic environment in order to avoid any contamination
of microbes in the products under testing.
Culture Media.
• Following culture media are used for conducting the sterility tests,
1. Fluid Thioglycollate Medium (FTM).
2. Alternative Thioglycollate Medium (ATM).
3. Soybean Casein Digest Medium (SCDM).
1. Fluid Thioglycollate Medium (FTM)
• For use with Clear fluid products.
• Mainly intended for “Anaerobic Bacteria” but can also detect Aerobic
Bacterias.
• It is an indicator culture medium as it contains “Resazurin” a dye which
becomes pink on contact with oxygen.
• While using not more than one tenth of the upper portion of the medium
should have pink color.
• If more than one third of the medium is looking pink (Showing presence of
oxygen) it can be simply restored by reheating in the water bath until color
disappears.
• pH: 7.1 ± 0.2.
• Sterilization: Autoclaving @ 121℃ for 20 mins.
2. Alternative Thioglycollate Medium (ATM):
• For use with turbid or viscous products and devices with small layers.
• It is an anaerobic medium i.e. made for cultivation of anaerobes and hence
anaerobic conditions must be followed while preparing and using.
• pH: 7.1 ± 0.2.
• Sterilization: Autoclaving @ 121℃ for 20 mins.
3. Soybean Casein Digest Medium (SCDM):
• Suitable for cultivation of both fungi and aerobic
bacterias.
• pH: 7.3 ± 0.2.
• Sterilization: Autoclaving @ 121℃ for 20 mins.
Sr No. Component FTM ATM SCDM
1 L-Cysteine 0.5 gm 0.5 gm --
2 Sodium CHloride 2.5 gm 5.5 gm 5. gm
3 Dextrose (Monohydrate or
Anhydrous)
5.5 gm / 5.0 gm 5.5 gm / 5.0 gm 2.5 gm / 2.3 gm
4 Yeast Extract (Water Soluble) 5.0 gm 5.0 gm --
5 Pancreatic Digest of Casein 15.0 gm 15.0 gm 17.0 gm
6 Sodium Thioglycollate /
Thioglycolic Acid
0.5 gm / 0. ml 0.5 gm / 0.3 ml --
7 Papic digest of Soybean meal -- -- 3.0 gm
8 Dipotassium Hydrogen
Phosphate
-- -- 2.5 gm
9 Resazurin Sodium 1.0 ml -- --
10 Distilled water upto 1000 ml 1000 ml 1000 ml
11 pH after Sterilization by
Autoclave @ 121℃ for 20
mins.
7.1 ± 0.2 7.1 ± 0.2 7.3 ± 0.2
Table 2.1: Composition of the Culture Medias used for Sterility Test.
Tests for Culture Media:
• The media to be used in sterility testings should pass the following tests,
1. Sterility of Media.
2. Growth Promotion Test.
3. Test for Bacteriostatic and Fungistatic.
1. Sterility of Media:
• Incubate the portions of FTM and ATM @ 30-35℃ and SCDM at 20-25℃ and
incubate them for not less than 14 days.
• The presence of microbial growth fails the test, while absence of growth passes
the test
2.Growth Promotion Test:
• This test is used to check the capability of the medium to promote the bacterial
growth.
• Medium sample from each autoclaved medium container is taken and inoculated with
about 100 test organisms of each “Test Strain” and incubated as per the requirements
of the given strain.
• The sample passess the test if it shows satisfactory growth of the organisms.
• The test is considered failed on inadequate growth of the microbes in the sample.
Medium Test Microorganisms Incubation Parameters
Temperature Duration in Days Conditions
FTM 1.Clostridium Sporogenes 30-35℃ 3 Anaerobic
2.Staphylococcus aureus 30-35℃ 3 Aerobic
3.Pseudomonas aeruginosa. 30-35℃ 3 Aerobic
ATM 1.Bacteroides vulgatus 30-35℃ 3 Anaerobic
2.Clostridium Sporogenes. 30-35℃ 3 Anaerobic
3.Bacillus subtilis. 30-35℃ 3 Aerobic
SCDM 1.Aspergillus brasiliensis 20-25℃ 5 Aerobic
2.Candida albicans 20-25℃ 5 Aerobic
3.Bacillus subtilis. 30-35℃ 3 Aerobic
Table 2.2: List of Test Microorganisms for the Growth Promotion Test of Media.
3) Test for Bacteriostatic and Fungistatic:
• Prepare cultures of the test bacterias and fungi.
• Inoculate the required volume of culture media with 100 viable microorganisms.
• Add the required amount of the preparation under test to the half of the
containers containing medium and microbes.
• The half of the containers are kept as control.
• After specified time the growth of microbes is visually compared in test and control
containers.
• If the test preparation is found to be bacteriostatic or fungistatic it can be neutralized
using “Neutralising agents” as specified.
Table 2.2: List of Neutralizing substances for antimicrobial compounds.
Sr No. Antimicrobial
agent
Neutralizing Agent.
1 Penicillin Penicillinase
2 Streptomycin Streptomycin
phosphotransferase
3 Cephalosporins Cephalosporinase.
4 Sulfonamides P Amino benzoic Acid
Sterility Test Methods.
• Sterility tests can be carried out using one of the following
methods,
1. Methods A: Membrane Filtration.
2. Method B: Direct Inoculation.
1. Method A: Membrane Filtration.
• This method is preferred when substance to be tested is,
a) an oil,
b) an ointment that can be put into solution,
c) a non bacteriostatic solid not readily soluble in the culture medium and
d) a soluble powder or a liquid that possesses inherent bacteriostatic and fungistatic properties.
• For liquid products where the volume > 100ml or more
• Precautions:
• A laminar sterile airflow cabinet – to avoid accidental contamination.
• Working conditions monitored regularly by sampling the air and surfaces of the working area.
• Apparatus:
• A suitable unit consists of a closed reservoir and a receptacle between which a
properly supported membrane of appropriate porosity is placed.
• Nominal pore size not > 0.45µm and diameter of approx. 47mm.
• Flow rate is adjusted to 55-75 ml of water / minute.
• Pressure 70 mm of Hg.
• Cellulose nitrate filter for aqueous, oily and weakly alcoholic solutions.
• Cellulose acetate solution for strong alcoholic solutions.
• Dilution Fluids:
• Fluid A: Dissolve 1g of peptic digest of animal tissue in water to make 1
liter, filter / centrifuge, adjust to pH 7.1±0.2, dispense into flasks in 100-
ml quantities and sterilise at 121º for 20 minutes.
• Fluid B: If the test sample contains lecithin or oil, use fluid A to each
liter of which has been added 1 ml of polysorbate 80, adjust to pH
7.1±0.2, dispense into flasks in 100-ml quantities and sterilise at 121º for
20 minutes.
• Quantities of sample to be used:
Table 3.1 Quantities of sample to be used:
Preparation Quantity in each container
of the preparation
Minimum quantity to be used for each culture medium
Liquids Less than 1 ml. Total contents of container.
1-40 ml Half of the container but not less than 1 ml.
40 ml to 100 ml. 20 ml
More than 100 ml 10% of the container but not less than 20 ml.
Antibiotic liquids 1 ml
Other soluble preparations The whole contents of each container to provide not less than 200mg.
Insoluble preparations ointments & creams. The whole contents of each container to provide not less than 200mg.
Solids Less than 50mg Total container.
50 mg - 300 mg Half of the container but not less than 50 mg.
300 mg - 5g 150 mg
More than 5 gm 500 mg
Catgut and other surgical sutures for veterinary use. Three sections of a strand each 30 cm long
Surgical dressings/ cotton/ gauze (In packages) 100 mg per package
Sutures and other individually packed single use material. Whole device
Other medical devices Whole device or material cut into pieces or diassembled
Method of test:
1) For aqueous solution: -
• Prepare each membrane by aseptically transferring fluid A + media + preparation being
examined. -
• Alternatively, first, combined quantities of preparation + prescribed in the two media.
• Draw the liquid rapidly through a filter with aid of vacuum.
• If the solution being examined has antimicrobial properties, wash the membrane by filtering
100ml of sterile fluid A, three times, or quantities should be sufficient to allow growth of small
inoculum of organisms.
• After filtration, aseptically remove membrane from holder, cut the membrane in half, immerse
one half of membrane in 100ml of soyabean-casein digest medium and incubate at 20º to 25º for
not < 7days.
• Similar, other membranes in FTM (30º to 35º).
2) For liquids immiscible with aqueous vehicles and suspensions: -
• Same as above but add sufficient quantity of fluid A to achieve rapid filtration.
• Sometimes use sterile enzyme preparations such as penicillinase or cellulase to aid in
dissolving insoluble substances.
• If lecithin is there, use fluid B for diluting.
3) For oils and oily solutions:
• Low viscous, filter without dilution through dry memb.
• Viscous oils – dilute as per needed using sterile diluent like isopropyl myristate –
filter by applying pressure or suction gradually.
• Wash the membrane at least 3 times sterile fluid B (100 ml) or to heat not > than 45º
and use warm solutions for washing membrane.
4) For ointments and creams:
• Dilute ointments in a fatty base and emulsions of the w/o type to give a fluid concentration of
1%w/v, by heating (if necessary), not > than 40º with a suitable sterile diluent.
5) For soluble solids:
• Dissolve substance in a suitable sterile solvent for each medium and carry out test described
under aqueous solutions.
6) For sterile devices:
• Aseptically pass a sufficient volume of fluid B through each of not less than 20 devices so that
not less than 100ml is recovered from each device.
• Collect fluids in sterile containers and filter the entire volume through a membrane filter funnel,
and follow the test as under for aqueous solutions.
2. Method B Direct Inoculation
•The quantities of substance or preparation being examined
which is to be used for inoculation for culture media varies
according to quantity in each container.
1) For aqueous solutions and suspensions:
• Remove liquid from test containers with a sterile pipette or with a sterile syringe
or a needle
• Aseptically transfer specified volume of the material from each container to a
vessel of the culture medium
• Mix the liquid with the medium but do not aerate excessively
• Incubate the inoculated media for not less than 14 days, unless otherwise
specified in the monograph.
• Incubate at 30º to 35º in case of fluid thioglycollate medium and at 20º to 25º in
case of soyabean casein digest medium.
• If a test sample renders the medium turbid, it is difficult to examine presence or
absence of microbial growth by visual examination.
• Transfer suitable portions of the same medium to fresh vessels between the third
and seventh days after the test is started.
• Continue incubation of transfer vessels for not less than 7 additional days after the
transfer and for a total of not less than 14 days
2) For oils and oily solutions:
• In media, add 0.1% w/v of (4 –tert -octylphenoxy) polyethoxy ethanol, 1% w/v of polysorbate
80 or other suitable emulsifying agent, in an appropriate conc.
• Oil containing cultures should be shaken gently each day.
3) For ointments: -
• Preparation is diluted tenfold in a sterile diluent such as fluid B or any other aqueous vehicle
capable of dispersing test material homogeneously throughout the fluid mixture.
• Mix 10ml of fluid mixture with 80 ml of the medium and proceed the same as aqueous
solutions & suspension.
4) For solids: -
• Transfer the required quantity of the material to the medium.
5) For sterile devices: -
• For articles of such size and shape as permit complete immersion in not more than
1000ml of culture medium test the intact article, using the appropriate media and
incubate same as 1).
• For transfusion or infusion assemblies or where the size of an item makes immersion
impracticable, flush the lumen of each of 20 units with a sufficient quantity of fluid
thioglycollate medium and soyabean casein medium to yield a recovery of not less than
15ml of each medium, and incubate with not less than 100 ml of each of two media.
• Where the presence of the specimen being tested interferes with the test because of
bacteriostatic action, rinse the article thoroughly with minimum amount of fluid A.
Recover the rinsed fluid and test as described for sterile devices under method A.
Observation and Interpretation of Results.
• At interval during incubation period, and at its conclusion, examine media for
macroscopic evidence of microbial growth.
• If no evidence of growth is found, the preparation being examined passes the test for
sterility.
• If evidence of microbial growth is found, reserve the containers, and it is demonstrated
that it is not due to preparation, hence the tests for sterility are invalid and may be
recommenced.
• Perform a retest using the same number of samples, volumes to be tested and the media
• if no evidence of microbial growth is then found, the preparation being examined passes the test
for sterility.
• If evidence of microbial growth is found, isolate and identify the organisms.
• If they are not readily distinguishable from those growing in the containers reserved in the first
test, the preparation being examined fails the test for sterility.
• If they are readily distinguishable from those growing in the containers reserved in the first test,
perform a second retest using twice the number of samples.
• If no evidence of microbial growth is found in the second retest, the preparation being examined
passes the test for sterility.
• If evidence of growth of any micro-organisms is found in second retest, the preparation being
examined fails the test for sterility.
Pyrogen Test Methods.
• Pyrogen tests can be carried out using one of the following
methods,
• Rabbit Test.
• LAL Test.
1. Rabbit Test.
• For this test, three healthy rabbits are selected each weighing at least 1.5
kg.
• No rabbit should be selected if:
• 1. It has a normal temperature greater than 49.8°C.
• 2. It was used in a positive test during the last two weeks.
•Method for Pyrogen Test:
• The pyrogen testing is performed in an air-conditioned room.
• The food and water is withheld from the rabbit overnight.
• A clinical thermometer is inserted in the rectum of each rabbit to a depth of
not less than 7.5 cm.
• Two readings of the temperature of rabbit in normal conditions should be taken
at the interval of half an hour before the start of the test and the mean of both
should be calculated to determine the initial temperature.
• The equipment, injectors and needles used in the test should be pyrogen-
free.
• These should be washed with water for injection and then heated at 260°C for
two hours.
• The injection is warmed to 38°C before injecting to the rabbits.
• 0.5 to 1.0 ml per kg dose should be injected through the ear vein.
• Six readings of temperature are recorded at an interval of half an hour.
• Pyrogen Test Results:
• The response of each rabbit is detected by the difference of initial temperature and the
highest temperature recorded.
• The response of all three rabbits gives the sum of responses and can be concluded as:
• i) If the sum of responses does not exceed 1.4°C and any rabbit shows the response less than 0.6° C,
the product passes the test.
• ii) If the sum of responses is greater than 1.4 °C or any rabbit shows the response 0.6 or greater,
continue the test using 5 rabbits.
• iii) If the test is done using 5 rabbits, then if the sum of responses of all 5 rabbits is greater than
3.7°C and the individual response of not more than three rabbits is greater than 0.6°C, the product
passes the test.
2. LAL Test.
• Also called “Limulus Amoebocyte Lysate Test” and “Bacterial Endotoxin
Test”.
• The LAL test reagent is prepared by lysing amoebocyte blood cells from
• American Horseshoe crab Limulus polyphemus and other species like
Tachyleus tridentus, Tachypleus gigas and Carcinoscropius rotundicauda.
• The horseshoe crab has blue colored blood.
• The amebocyte blood cells of horseshoe crab show defensive clotting
in presence of bacterial endotoxins.
• When a test material containing a pyrogen is added to the LAL reagent
it forms turbidity or a gel consistency indicating presence of
endotoxins.
• The test is 100 times more sensitive than the rabbit test.
• LAL reagent is available commercially and is a popular alternative to
animal tests.
THANK YOU

More Related Content

What's hot

Evaluation of Bactericidal and Bacteriostatic
Evaluation of Bactericidal and BacteriostaticEvaluation of Bactericidal and Bacteriostatic
Evaluation of Bactericidal and Bacteriostatic
Rajsingh467604
 
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...
Ms. Pooja Bhandare
 
Evaluation of the efficiency of sterilization methods. Sterility indicators
Evaluation of the efficiency of sterilization methods.Sterility indicatorsEvaluation of the efficiency of sterilization methods.Sterility indicators
Evaluation of the efficiency of sterilization methods. Sterility indicators
Ms. Pooja Bhandare
 
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...
Ms. Pooja Bhandare
 
Microbiological assay of antibiotics
Microbiological assay of antibioticsMicrobiological assay of antibiotics
Microbiological assay of antibiotics
monnask
 
Designing of aseptic area
Designing of aseptic areaDesigning of aseptic area
Designing of aseptic area
someshwar mankar
 
Microbiological assay-Principles and methods of different microbiological assay.
Microbiological assay-Principles and methods of different microbiological assay.Microbiological assay-Principles and methods of different microbiological assay.
Microbiological assay-Principles and methods of different microbiological assay.
someshwar mankar
 
Pharmaceutical engineering: Distillation
Pharmaceutical engineering: DistillationPharmaceutical engineering: Distillation
Pharmaceutical engineering: Distillation
Parag Jain
 
Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...
Ms. Pooja Bhandare
 
Disinfectant - Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Disinfectant - Pharmaceutical microbiology (Second year b.pharm) (3rd semester)Disinfectant - Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Disinfectant - Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Kiran Shinde
 
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Ms. Pooja Bhandare
 
Study of principle, procedure, merits, demerits and applications of physical,...
Study of principle, procedure, merits, demerits and applications of physical,...Study of principle, procedure, merits, demerits and applications of physical,...
Study of principle, procedure, merits, demerits and applications of physical,...
Ms. Pooja Bhandare
 
Microbial assay of B2 and B12
Microbial assay of B2 and B12Microbial assay of B2 and B12
Microbial assay of B2 and B12
Pankhil Gandhi
 
Microbiological Assay
Microbiological AssayMicrobiological Assay
Microbiological Assay
vaibhavnamdev5
 
Raw material and nutrition
Raw material and nutritionRaw material and nutrition
Raw material and nutrition
Chaitali Kalamkar
 
Pharmaceutical Engineering: Filtration
Pharmaceutical Engineering: Filtration Pharmaceutical Engineering: Filtration
Pharmaceutical Engineering: Filtration
Parag Jain
 
VIRUS PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-2Study of morphology, ...
VIRUS PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-2Study of morphology, ...VIRUS PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-2Study of morphology, ...
VIRUS PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-2Study of morphology, ...
Ms. Pooja Bhandare
 
Evaluation of disinfectant
Evaluation of disinfectantEvaluation of disinfectant
Evaluation of disinfectant
Ikenna Godwin
 

What's hot (20)

Evaluation of Bactericidal and Bacteriostatic
Evaluation of Bactericidal and BacteriostaticEvaluation of Bactericidal and Bacteriostatic
Evaluation of Bactericidal and Bacteriostatic
 
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...
Assessment of microbial contamination and spoilage. PHARMACEUTICAL MICROBIOLO...
 
Evaluation of the efficiency of sterilization methods. Sterility indicators
Evaluation of the efficiency of sterilization methods.Sterility indicatorsEvaluation of the efficiency of sterilization methods.Sterility indicators
Evaluation of the efficiency of sterilization methods. Sterility indicators
 
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...
Evaluation of Bactericidal and Bacteriostatic (Disinfectant). PHARMACEUTICAL ...
 
Microbiological assay of antibiotics
Microbiological assay of antibioticsMicrobiological assay of antibiotics
Microbiological assay of antibiotics
 
Sterility testing
Sterility testingSterility testing
Sterility testing
 
Designing of aseptic area
Designing of aseptic areaDesigning of aseptic area
Designing of aseptic area
 
Microbiological assay-Principles and methods of different microbiological assay.
Microbiological assay-Principles and methods of different microbiological assay.Microbiological assay-Principles and methods of different microbiological assay.
Microbiological assay-Principles and methods of different microbiological assay.
 
Pharmaceutical engineering: Distillation
Pharmaceutical engineering: DistillationPharmaceutical engineering: Distillation
Pharmaceutical engineering: Distillation
 
Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...Designing of aseptic area, laminar flow equipment: Study of different source ...
Designing of aseptic area, laminar flow equipment: Study of different source ...
 
Disinfectant - Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Disinfectant - Pharmaceutical microbiology (Second year b.pharm) (3rd semester)Disinfectant - Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Disinfectant - Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
 
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
Types of spoilage, factors affecting the microbial spoilage of pharmaceutical...
 
Study of principle, procedure, merits, demerits and applications of physical,...
Study of principle, procedure, merits, demerits and applications of physical,...Study of principle, procedure, merits, demerits and applications of physical,...
Study of principle, procedure, merits, demerits and applications of physical,...
 
Microbial assay of B2 and B12
Microbial assay of B2 and B12Microbial assay of B2 and B12
Microbial assay of B2 and B12
 
Microbiological Assay
Microbiological AssayMicrobiological Assay
Microbiological Assay
 
Raw material and nutrition
Raw material and nutritionRaw material and nutrition
Raw material and nutrition
 
Microbiological assay
Microbiological assayMicrobiological assay
Microbiological assay
 
Pharmaceutical Engineering: Filtration
Pharmaceutical Engineering: Filtration Pharmaceutical Engineering: Filtration
Pharmaceutical Engineering: Filtration
 
VIRUS PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-2Study of morphology, ...
VIRUS PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-2Study of morphology, ...VIRUS PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-2Study of morphology, ...
VIRUS PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-2Study of morphology, ...
 
Evaluation of disinfectant
Evaluation of disinfectantEvaluation of disinfectant
Evaluation of disinfectant
 

Similar to Sterility testing products (solids, liquids, ophthalmic and other sterile products) according to IP, BP, USP. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-6

USP STERILITY TESTING BY ROSHAN GOMAJI BODHE
USP STERILITY TESTING BY ROSHAN GOMAJI BODHEUSP STERILITY TESTING BY ROSHAN GOMAJI BODHE
USP STERILITY TESTING BY ROSHAN GOMAJI BODHE
Roshan Bodhe
 
Sterility testing USP 71
Sterility testing USP 71Sterility testing USP 71
Sterility testing USP 71
Gibraltar Laboratories
 
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTSIPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
SaiBapat
 
Preparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteralPreparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteral
sangram maskar
 
Lab experiment sterility testing
Lab experiment sterility testingLab experiment sterility testing
Lab experiment sterility testing
Saira Fatima
 
Sterility test
Sterility testSterility test
Sterility test
Asim Ahmad
 
Evaluaton of parentrals
Evaluaton of parentralsEvaluaton of parentrals
Evaluaton of parentrals
SUJIT DAS
 
Zearalenone
ZearalenoneZearalenone
Zearalenone
mzk57
 
Usp 40 -71 sterility tests
Usp 40 -71 sterility testsUsp 40 -71 sterility tests
Usp 40 -71 sterility tests
Bhargava Gottam
 
Sterility test and modern microbiological methods
Sterility test and modern microbiological methodsSterility test and modern microbiological methods
Sterility test and modern microbiological methodsMohammed Fawzy
 
Sterile Products & admixtures
Sterile Products & admixturesSterile Products & admixtures
Sterile Products & admixtures
Rameshwar Madharia
 
Microbial limit test 112070804013
Microbial limit test  112070804013Microbial limit test  112070804013
Microbial limit test 112070804013Patel Parth
 
Total aflatoxin
Total aflatoxinTotal aflatoxin
Total aflatoxin
mzk57
 
Parenterals
ParenteralsParenterals
Parenterals
Rameshwar Madharia
 
Quality control tests for parenterals ppt
Quality  control  tests  for  parenterals pptQuality  control  tests  for  parenterals ppt
Quality control tests for parenterals ppt
suraj p rajan
 
Human orosomucoid-2-elisa-kit
Human orosomucoid-2-elisa-kitHuman orosomucoid-2-elisa-kit
Human orosomucoid-2-elisa-kit
David tong
 
3. Antimicrobial Effectiveness Final.pptx
3. Antimicrobial Effectiveness Final.pptx3. Antimicrobial Effectiveness Final.pptx
3. Antimicrobial Effectiveness Final.pptx
Rushikesh Tamhane
 
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsIn Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
Sagar Savale
 
EVALUATION OF PARENTERALS.pptx
EVALUATION OF PARENTERALS.pptxEVALUATION OF PARENTERALS.pptx
EVALUATION OF PARENTERALS.pptx
bharatibakde1
 

Similar to Sterility testing products (solids, liquids, ophthalmic and other sterile products) according to IP, BP, USP. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-6 (20)

USP STERILITY TESTING BY ROSHAN GOMAJI BODHE
USP STERILITY TESTING BY ROSHAN GOMAJI BODHEUSP STERILITY TESTING BY ROSHAN GOMAJI BODHE
USP STERILITY TESTING BY ROSHAN GOMAJI BODHE
 
Ipqc tests for parentrals
Ipqc tests for parentralsIpqc tests for parentrals
Ipqc tests for parentrals
 
Sterility testing USP 71
Sterility testing USP 71Sterility testing USP 71
Sterility testing USP 71
 
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTSIPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
IPQC FOR PARENTRALS AND OPTHALMIC PRODUCTS
 
Preparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteralPreparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteral
 
Lab experiment sterility testing
Lab experiment sterility testingLab experiment sterility testing
Lab experiment sterility testing
 
Sterility test
Sterility testSterility test
Sterility test
 
Evaluaton of parentrals
Evaluaton of parentralsEvaluaton of parentrals
Evaluaton of parentrals
 
Zearalenone
ZearalenoneZearalenone
Zearalenone
 
Usp 40 -71 sterility tests
Usp 40 -71 sterility testsUsp 40 -71 sterility tests
Usp 40 -71 sterility tests
 
Sterility test and modern microbiological methods
Sterility test and modern microbiological methodsSterility test and modern microbiological methods
Sterility test and modern microbiological methods
 
Sterile Products & admixtures
Sterile Products & admixturesSterile Products & admixtures
Sterile Products & admixtures
 
Microbial limit test 112070804013
Microbial limit test  112070804013Microbial limit test  112070804013
Microbial limit test 112070804013
 
Total aflatoxin
Total aflatoxinTotal aflatoxin
Total aflatoxin
 
Parenterals
ParenteralsParenterals
Parenterals
 
Quality control tests for parenterals ppt
Quality  control  tests  for  parenterals pptQuality  control  tests  for  parenterals ppt
Quality control tests for parenterals ppt
 
Human orosomucoid-2-elisa-kit
Human orosomucoid-2-elisa-kitHuman orosomucoid-2-elisa-kit
Human orosomucoid-2-elisa-kit
 
3. Antimicrobial Effectiveness Final.pptx
3. Antimicrobial Effectiveness Final.pptx3. Antimicrobial Effectiveness Final.pptx
3. Antimicrobial Effectiveness Final.pptx
 
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsIn Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage Forms
 
EVALUATION OF PARENTERALS.pptx
EVALUATION OF PARENTERALS.pptxEVALUATION OF PARENTERALS.pptx
EVALUATION OF PARENTERALS.pptx
 

More from Ms. Pooja Bhandare

Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Ms. Pooja Bhandare
 
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxPharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Ms. Pooja Bhandare
 
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptxGastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Ms. Pooja Bhandare
 
Dental products.pptx
Dental products.pptxDental products.pptx
Dental products.pptx
Ms. Pooja Bhandare
 
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Ms. Pooja Bhandare
 
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Ms. Pooja Bhandare
 
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit TestLimt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Ms. Pooja Bhandare
 
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Ms. Pooja Bhandare
 
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxIntroduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Ms. Pooja Bhandare
 
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Ms. Pooja Bhandare
 
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Ms. Pooja Bhandare
 
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...
Ms. Pooja Bhandare
 
Cultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptxCultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptx
Ms. Pooja Bhandare
 
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Ms. Pooja Bhandare
 
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Ms. Pooja Bhandare
 
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptxPharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Ms. Pooja Bhandare
 
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Ms. Pooja Bhandare
 
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Ms. Pooja Bhandare
 
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Ms. Pooja Bhandare
 
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...
Ms. Pooja Bhandare
 

More from Ms. Pooja Bhandare (20)

Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
Pharmaceutical Inorganic Chemistry Unit IVMiscellaneous compounds Expectorant...
 
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptxPharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
Pharmaceutical Inorganic chemistry UNIT-V Radiopharmaceutical.pptx
 
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptxGastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
Gastrointestinal agents.Pharmaceutical Inorganic chemistry UNIT-III pptx
 
Dental products.pptx
Dental products.pptxDental products.pptx
Dental products.pptx
 
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
Major extra and intracellular electrolytes. Pharmaceutical Inorganic chemistr...
 
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
Acids, Bases And Buffers Pharmaceutical Inorganic chemistry UNIT-II (Part-I)
 
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit TestLimt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
Limt test Pharmaceutical Inorganic chemistry UNIT-I (Part-III) Limit Test
 
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
Types and Sources of impurities.pptx Pharmaceutical Inorganic chemistry UNIT-...
 
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptxIntroduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
Introduction of Inorganic Chemistry, History of Pharmacopoeia.pptx
 
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
Polyploidy, mutation and hybridization with reference to medicinal plants. PH...
 
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
Plant Growth Regulators Plant Harmone Phytoharmone. PHARMACOGNOSY & Phytochem...
 
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T)Uni...
FACTORS AFFECTING CULTIVATION. PHARMACOGNOSY & Phytochemistry-I (BP405T) Uni...
 
Cultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptxCultivation and collections of drugs of natural origin..pptx
Cultivation and collections of drugs of natural origin..pptx
 
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
Quality control of Drugs of Natural Origin. PHARMACognosy & Phytochemistry-I ...
 
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
Classification of Crude Drugs. HARMACognosy & Phytochemistry-I (BP405T)Unit-I...
 
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptxPharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
Pharmacognosy & Phytochemistry-I Unit-IPart-1Introduction of Pharmacognosy..pptx
 
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
Applications of cell culture. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-VPart-5
 
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
Animal Cell Culture: Growth of animal cells in culture. PHARMACEUTICAL MICROB...
 
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
Factors affecting action of Disinfectants and Factors Affecting Choice Of Ant...
 
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...
Classification and mode of action of disinfectants PHARMACEUTICAL MICROBIOLOG...
 

Recently uploaded

South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 

Recently uploaded (20)

South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 

Sterility testing products (solids, liquids, ophthalmic and other sterile products) according to IP, BP, USP. PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-6

  • 1. PHARMACEUTICAL MICROBIOLOGY (BP303T) Unit-III Part-6 Sterility testing products (solids, liquids, ophthalmic and other sterile products) according to IP, BP, USP. Name: Ms. Pooja Deepak Bhandare Assistant Professor G H RAISONI UNIVERSITY SCHOOL OF PHARMACY
  • 2. Introduction • Sterilization is the process of complete removal of microorganisms from any surface or product. • Sterility hence can be defined as “Complete freedom from microorganisms”. • The tests for sterility are conducted to make sure there is complete absence of viable forms of microorganisms on a pharmaceutical product. • The products which are to be strictly supervised for absence of the microorganisms are those who come directly in contact with the systemic circulation e.g. ophthalmic preparations, parenteral injections, implants, bandages, surgical dressings, needles, surgical instruments etc. • The test for sterility has to be conducted in aseptic environment so as to avoid the contamination of the product.
  • 3. • A pyrogen can be defined as “Fever Producing Substance”, which induces “Fever (Hyperpyrexia)”. • Bacterial endotoxins are the most common type of “Exogenous Pyrogen”. • Bacteria, viruses, malaria parasites and fungi on entering in the body releases certain chemicals that act as Pyrogen. • During the sterilization process these microorganisms die but presence of pyrogens in the products may cause a febrile reaction. • Test for sterility ensures absence of microorganisms while the Pyrogen test ensures absence of pyrogens in the pharmaceutical products. • The lipopolysaccharide (LPS) from gram negative bacterias is a very common example of pyrogen. • The common pyrogen tests are, • LAL Test (Limulus Amoebecyte Lysate Test). • Sham Test (Rabbit Test).
  • 4. Test for Sterility. • Principle: • A viable microorganism when provided with favorable conditions and nutrients shows growth indicating its presence in the product. • The probability of detecting the microbes in a product increases with the number of the testings done. • The external surfaces of the ampoules and vials or the containers should be cleaned with the suitable antimicrobial substance and test be carried out in an aseptic environment in order to avoid any contamination of microbes in the products under testing.
  • 5. Culture Media. • Following culture media are used for conducting the sterility tests, 1. Fluid Thioglycollate Medium (FTM). 2. Alternative Thioglycollate Medium (ATM). 3. Soybean Casein Digest Medium (SCDM).
  • 6. 1. Fluid Thioglycollate Medium (FTM) • For use with Clear fluid products. • Mainly intended for “Anaerobic Bacteria” but can also detect Aerobic Bacterias. • It is an indicator culture medium as it contains “Resazurin” a dye which becomes pink on contact with oxygen. • While using not more than one tenth of the upper portion of the medium should have pink color. • If more than one third of the medium is looking pink (Showing presence of oxygen) it can be simply restored by reheating in the water bath until color disappears. • pH: 7.1 ± 0.2. • Sterilization: Autoclaving @ 121℃ for 20 mins.
  • 7. 2. Alternative Thioglycollate Medium (ATM): • For use with turbid or viscous products and devices with small layers. • It is an anaerobic medium i.e. made for cultivation of anaerobes and hence anaerobic conditions must be followed while preparing and using. • pH: 7.1 ± 0.2. • Sterilization: Autoclaving @ 121℃ for 20 mins.
  • 8. 3. Soybean Casein Digest Medium (SCDM): • Suitable for cultivation of both fungi and aerobic bacterias. • pH: 7.3 ± 0.2. • Sterilization: Autoclaving @ 121℃ for 20 mins.
  • 9. Sr No. Component FTM ATM SCDM 1 L-Cysteine 0.5 gm 0.5 gm -- 2 Sodium CHloride 2.5 gm 5.5 gm 5. gm 3 Dextrose (Monohydrate or Anhydrous) 5.5 gm / 5.0 gm 5.5 gm / 5.0 gm 2.5 gm / 2.3 gm 4 Yeast Extract (Water Soluble) 5.0 gm 5.0 gm -- 5 Pancreatic Digest of Casein 15.0 gm 15.0 gm 17.0 gm 6 Sodium Thioglycollate / Thioglycolic Acid 0.5 gm / 0. ml 0.5 gm / 0.3 ml -- 7 Papic digest of Soybean meal -- -- 3.0 gm 8 Dipotassium Hydrogen Phosphate -- -- 2.5 gm 9 Resazurin Sodium 1.0 ml -- -- 10 Distilled water upto 1000 ml 1000 ml 1000 ml 11 pH after Sterilization by Autoclave @ 121℃ for 20 mins. 7.1 ± 0.2 7.1 ± 0.2 7.3 ± 0.2 Table 2.1: Composition of the Culture Medias used for Sterility Test.
  • 10. Tests for Culture Media: • The media to be used in sterility testings should pass the following tests, 1. Sterility of Media. 2. Growth Promotion Test. 3. Test for Bacteriostatic and Fungistatic. 1. Sterility of Media: • Incubate the portions of FTM and ATM @ 30-35℃ and SCDM at 20-25℃ and incubate them for not less than 14 days. • The presence of microbial growth fails the test, while absence of growth passes the test
  • 11. 2.Growth Promotion Test: • This test is used to check the capability of the medium to promote the bacterial growth. • Medium sample from each autoclaved medium container is taken and inoculated with about 100 test organisms of each “Test Strain” and incubated as per the requirements of the given strain. • The sample passess the test if it shows satisfactory growth of the organisms. • The test is considered failed on inadequate growth of the microbes in the sample.
  • 12. Medium Test Microorganisms Incubation Parameters Temperature Duration in Days Conditions FTM 1.Clostridium Sporogenes 30-35℃ 3 Anaerobic 2.Staphylococcus aureus 30-35℃ 3 Aerobic 3.Pseudomonas aeruginosa. 30-35℃ 3 Aerobic ATM 1.Bacteroides vulgatus 30-35℃ 3 Anaerobic 2.Clostridium Sporogenes. 30-35℃ 3 Anaerobic 3.Bacillus subtilis. 30-35℃ 3 Aerobic SCDM 1.Aspergillus brasiliensis 20-25℃ 5 Aerobic 2.Candida albicans 20-25℃ 5 Aerobic 3.Bacillus subtilis. 30-35℃ 3 Aerobic Table 2.2: List of Test Microorganisms for the Growth Promotion Test of Media.
  • 13. 3) Test for Bacteriostatic and Fungistatic: • Prepare cultures of the test bacterias and fungi. • Inoculate the required volume of culture media with 100 viable microorganisms. • Add the required amount of the preparation under test to the half of the containers containing medium and microbes. • The half of the containers are kept as control. • After specified time the growth of microbes is visually compared in test and control containers. • If the test preparation is found to be bacteriostatic or fungistatic it can be neutralized using “Neutralising agents” as specified.
  • 14. Table 2.2: List of Neutralizing substances for antimicrobial compounds. Sr No. Antimicrobial agent Neutralizing Agent. 1 Penicillin Penicillinase 2 Streptomycin Streptomycin phosphotransferase 3 Cephalosporins Cephalosporinase. 4 Sulfonamides P Amino benzoic Acid
  • 15. Sterility Test Methods. • Sterility tests can be carried out using one of the following methods, 1. Methods A: Membrane Filtration. 2. Method B: Direct Inoculation.
  • 16. 1. Method A: Membrane Filtration. • This method is preferred when substance to be tested is, a) an oil, b) an ointment that can be put into solution, c) a non bacteriostatic solid not readily soluble in the culture medium and d) a soluble powder or a liquid that possesses inherent bacteriostatic and fungistatic properties. • For liquid products where the volume > 100ml or more • Precautions: • A laminar sterile airflow cabinet – to avoid accidental contamination. • Working conditions monitored regularly by sampling the air and surfaces of the working area.
  • 17. • Apparatus: • A suitable unit consists of a closed reservoir and a receptacle between which a properly supported membrane of appropriate porosity is placed. • Nominal pore size not > 0.45µm and diameter of approx. 47mm. • Flow rate is adjusted to 55-75 ml of water / minute. • Pressure 70 mm of Hg. • Cellulose nitrate filter for aqueous, oily and weakly alcoholic solutions. • Cellulose acetate solution for strong alcoholic solutions.
  • 18. • Dilution Fluids: • Fluid A: Dissolve 1g of peptic digest of animal tissue in water to make 1 liter, filter / centrifuge, adjust to pH 7.1±0.2, dispense into flasks in 100- ml quantities and sterilise at 121º for 20 minutes. • Fluid B: If the test sample contains lecithin or oil, use fluid A to each liter of which has been added 1 ml of polysorbate 80, adjust to pH 7.1±0.2, dispense into flasks in 100-ml quantities and sterilise at 121º for 20 minutes. • Quantities of sample to be used:
  • 19. Table 3.1 Quantities of sample to be used: Preparation Quantity in each container of the preparation Minimum quantity to be used for each culture medium Liquids Less than 1 ml. Total contents of container. 1-40 ml Half of the container but not less than 1 ml. 40 ml to 100 ml. 20 ml More than 100 ml 10% of the container but not less than 20 ml. Antibiotic liquids 1 ml Other soluble preparations The whole contents of each container to provide not less than 200mg. Insoluble preparations ointments & creams. The whole contents of each container to provide not less than 200mg. Solids Less than 50mg Total container. 50 mg - 300 mg Half of the container but not less than 50 mg. 300 mg - 5g 150 mg More than 5 gm 500 mg Catgut and other surgical sutures for veterinary use. Three sections of a strand each 30 cm long Surgical dressings/ cotton/ gauze (In packages) 100 mg per package Sutures and other individually packed single use material. Whole device Other medical devices Whole device or material cut into pieces or diassembled
  • 20. Method of test: 1) For aqueous solution: - • Prepare each membrane by aseptically transferring fluid A + media + preparation being examined. - • Alternatively, first, combined quantities of preparation + prescribed in the two media. • Draw the liquid rapidly through a filter with aid of vacuum. • If the solution being examined has antimicrobial properties, wash the membrane by filtering 100ml of sterile fluid A, three times, or quantities should be sufficient to allow growth of small inoculum of organisms. • After filtration, aseptically remove membrane from holder, cut the membrane in half, immerse one half of membrane in 100ml of soyabean-casein digest medium and incubate at 20º to 25º for not < 7days. • Similar, other membranes in FTM (30º to 35º).
  • 21. 2) For liquids immiscible with aqueous vehicles and suspensions: - • Same as above but add sufficient quantity of fluid A to achieve rapid filtration. • Sometimes use sterile enzyme preparations such as penicillinase or cellulase to aid in dissolving insoluble substances. • If lecithin is there, use fluid B for diluting. 3) For oils and oily solutions: • Low viscous, filter without dilution through dry memb. • Viscous oils – dilute as per needed using sterile diluent like isopropyl myristate – filter by applying pressure or suction gradually. • Wash the membrane at least 3 times sterile fluid B (100 ml) or to heat not > than 45º and use warm solutions for washing membrane.
  • 22. 4) For ointments and creams: • Dilute ointments in a fatty base and emulsions of the w/o type to give a fluid concentration of 1%w/v, by heating (if necessary), not > than 40º with a suitable sterile diluent. 5) For soluble solids: • Dissolve substance in a suitable sterile solvent for each medium and carry out test described under aqueous solutions. 6) For sterile devices: • Aseptically pass a sufficient volume of fluid B through each of not less than 20 devices so that not less than 100ml is recovered from each device. • Collect fluids in sterile containers and filter the entire volume through a membrane filter funnel, and follow the test as under for aqueous solutions.
  • 23. 2. Method B Direct Inoculation •The quantities of substance or preparation being examined which is to be used for inoculation for culture media varies according to quantity in each container.
  • 24. 1) For aqueous solutions and suspensions: • Remove liquid from test containers with a sterile pipette or with a sterile syringe or a needle • Aseptically transfer specified volume of the material from each container to a vessel of the culture medium • Mix the liquid with the medium but do not aerate excessively • Incubate the inoculated media for not less than 14 days, unless otherwise specified in the monograph. • Incubate at 30º to 35º in case of fluid thioglycollate medium and at 20º to 25º in case of soyabean casein digest medium. • If a test sample renders the medium turbid, it is difficult to examine presence or absence of microbial growth by visual examination. • Transfer suitable portions of the same medium to fresh vessels between the third and seventh days after the test is started. • Continue incubation of transfer vessels for not less than 7 additional days after the transfer and for a total of not less than 14 days
  • 25. 2) For oils and oily solutions: • In media, add 0.1% w/v of (4 –tert -octylphenoxy) polyethoxy ethanol, 1% w/v of polysorbate 80 or other suitable emulsifying agent, in an appropriate conc. • Oil containing cultures should be shaken gently each day. 3) For ointments: - • Preparation is diluted tenfold in a sterile diluent such as fluid B or any other aqueous vehicle capable of dispersing test material homogeneously throughout the fluid mixture. • Mix 10ml of fluid mixture with 80 ml of the medium and proceed the same as aqueous solutions & suspension. 4) For solids: - • Transfer the required quantity of the material to the medium.
  • 26. 5) For sterile devices: - • For articles of such size and shape as permit complete immersion in not more than 1000ml of culture medium test the intact article, using the appropriate media and incubate same as 1). • For transfusion or infusion assemblies or where the size of an item makes immersion impracticable, flush the lumen of each of 20 units with a sufficient quantity of fluid thioglycollate medium and soyabean casein medium to yield a recovery of not less than 15ml of each medium, and incubate with not less than 100 ml of each of two media. • Where the presence of the specimen being tested interferes with the test because of bacteriostatic action, rinse the article thoroughly with minimum amount of fluid A. Recover the rinsed fluid and test as described for sterile devices under method A.
  • 27. Observation and Interpretation of Results. • At interval during incubation period, and at its conclusion, examine media for macroscopic evidence of microbial growth. • If no evidence of growth is found, the preparation being examined passes the test for sterility. • If evidence of microbial growth is found, reserve the containers, and it is demonstrated that it is not due to preparation, hence the tests for sterility are invalid and may be recommenced. • Perform a retest using the same number of samples, volumes to be tested and the media • if no evidence of microbial growth is then found, the preparation being examined passes the test for sterility. • If evidence of microbial growth is found, isolate and identify the organisms. • If they are not readily distinguishable from those growing in the containers reserved in the first test, the preparation being examined fails the test for sterility. • If they are readily distinguishable from those growing in the containers reserved in the first test, perform a second retest using twice the number of samples. • If no evidence of microbial growth is found in the second retest, the preparation being examined passes the test for sterility. • If evidence of growth of any micro-organisms is found in second retest, the preparation being examined fails the test for sterility.
  • 28. Pyrogen Test Methods. • Pyrogen tests can be carried out using one of the following methods, • Rabbit Test. • LAL Test.
  • 29. 1. Rabbit Test. • For this test, three healthy rabbits are selected each weighing at least 1.5 kg. • No rabbit should be selected if: • 1. It has a normal temperature greater than 49.8°C. • 2. It was used in a positive test during the last two weeks.
  • 31. • The pyrogen testing is performed in an air-conditioned room. • The food and water is withheld from the rabbit overnight. • A clinical thermometer is inserted in the rectum of each rabbit to a depth of not less than 7.5 cm. • Two readings of the temperature of rabbit in normal conditions should be taken at the interval of half an hour before the start of the test and the mean of both should be calculated to determine the initial temperature. • The equipment, injectors and needles used in the test should be pyrogen- free. • These should be washed with water for injection and then heated at 260°C for two hours. • The injection is warmed to 38°C before injecting to the rabbits. • 0.5 to 1.0 ml per kg dose should be injected through the ear vein. • Six readings of temperature are recorded at an interval of half an hour.
  • 32. • Pyrogen Test Results: • The response of each rabbit is detected by the difference of initial temperature and the highest temperature recorded. • The response of all three rabbits gives the sum of responses and can be concluded as: • i) If the sum of responses does not exceed 1.4°C and any rabbit shows the response less than 0.6° C, the product passes the test. • ii) If the sum of responses is greater than 1.4 °C or any rabbit shows the response 0.6 or greater, continue the test using 5 rabbits. • iii) If the test is done using 5 rabbits, then if the sum of responses of all 5 rabbits is greater than 3.7°C and the individual response of not more than three rabbits is greater than 0.6°C, the product passes the test.
  • 33. 2. LAL Test. • Also called “Limulus Amoebocyte Lysate Test” and “Bacterial Endotoxin Test”. • The LAL test reagent is prepared by lysing amoebocyte blood cells from • American Horseshoe crab Limulus polyphemus and other species like Tachyleus tridentus, Tachypleus gigas and Carcinoscropius rotundicauda.
  • 34. • The horseshoe crab has blue colored blood. • The amebocyte blood cells of horseshoe crab show defensive clotting in presence of bacterial endotoxins. • When a test material containing a pyrogen is added to the LAL reagent it forms turbidity or a gel consistency indicating presence of endotoxins. • The test is 100 times more sensitive than the rabbit test. • LAL reagent is available commercially and is a popular alternative to animal tests.